Anagrelide hydrochloride

BMS-599626 Hydrochloride (AC480 Hydrochloride) is a selective and orally bioavailable HER1 and HER2 inhibitor, with IC 50 s of 20 and 30 nM, respectively. BMS-599626 Hydrochloride displays ~8-fold less potent to HER4 (IC 50 =190 nM), &gt:100-fold to

Synonyms: Boc-Piz·HCl Purity Limit: &ge 99% (HPLC) CAS No.: 76535-74-5 Molecular Formula: C9H18N2O2·HCl Molecular Weight: 222.72 MDL No.: MFCD00673776 Melting Point: 233-237º C Storage Temperature: Store at 0-8°C

MF: C9H18N2O2 . HCl MF: 222.72 CAS: 76535-74-5 Purity: >99% by HPLC

Boc-Val-Pro-Arg-MCA hydrochloride is a sensitive fluorogenic substrate for measuring trypsin-like serine proteases activity.In VitroGuidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified

Boc-Val-Pro-Arg-MCA hydrochloride is a sensitive fluorogenic substrate for measuring trypsin-like serine proteases activity.In VitroGuidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified

Boron trichloride (BCl 3 ) is a boron halide typically used as a reagent in organic synthesis for the cleavage of C-O bonds in ethers. Application Boron trichloride (BCl 3 ) can be used as a reactant in the preperation of borazine-linked polymer

Boron trichloride (BCl 3 ) is a boron halide typically used as a reagent in organic synthesis for the cleavage of C-O bonds in ethers. Application Boron trichloride (BCl 3 ) can be used as a reactant in the preperation of borazine-linked polymer

A linear imidazoquinazoline that potently and selectively inhibits the tyrosine kinase activity of EGFR (IC₅₀ = 8 pM).

BRD5648 ((R)-BRD0705) is a negative control of BRD0705. BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor with an IC 50 of 66 nM and a K d of 4.8 μM. BRD0705 displays increased selectivity for GSK3α (8-fold) versus GSK3β (IC

BRD5648 ((R)-BRD0705) is a negative control of BRD0705. BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor with an IC 50 of 66 nM and a K d of 4.8 μM. BRD0705 displays increased selectivity for GSK3α (8-fold) versus GSK3β (IC

BRD5648 ((R)-BRD0705) is a negative control of BRD0705. BRD0705 is a potent, paralog selective and orally active GSK3α inhibitor with an IC 50 of 66 nM and a K d of 4.8 μM. BRD0705 displays increased selectivity for GSK3α (8-fold) versus GSK3β (IC

Biochem/physiol Actions I 2 Imidazoline receptor antagonist. Features and Benefits This compound is featured on the Imidazoline Binding Sites page of the Handbook of Receptor Classification and Signal Transduction.